Overview
Elementis, an FTSE 250 company, is a global specialty chemicals company that offers performance-driven additives that help create innovative formulations for consumer and industrial applications. Combining its leading positions in the science of materials flow, surface modification, and formulation with access to unique natural materials, Elementis delivers unique chemistry, and sustainable solutions to customers in a wide range of markets, including
...
Read More cosmetics, antiperspirants, decorative and industrial coatings, automotive, and ceramics. Some of its offerings include rheology modifiers, high-purity talc, hectorite, organoclays, natural oils, dispersants, hectorite derivatives, and other specialty additives. The vast majority of its revenue comes from international customers.
Read Less
Read More cosmetics, antiperspirants, decorative and industrial coatings, automotive, and ceramics. Some of its offerings include rheology modifiers, high-purity talc, hectorite, organoclays, natural oils, dispersants, hectorite derivatives, and other specialty additives. The vast majority of its revenue comes from international customers.
Read Less
John Edward O'Higgins
See more contacts
Management of Companies and Enterprises
,
Other Chemical Product and Preparation Manufacturing
,
Holding companies, nec
,
Chemical preparations, nec
?
Estimated
$738.30 million
Actual
3.49%
$1,308
DEC
?
?
London SETS:ELM
Contacts
Get in Touch with 11 Principals* and 8 Contacts
-
John Edward O'HigginsDirector
-
Contact 2?
-
Contact 3?
-
Contact 4?
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Statements
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Financial data as of December 31, 2024 (12 month period) in USD
Annual Revenue 2024
$738.30 million
USD
Actual
All financial statement data is in millions except per share data | Source: Morningstar
| Cash Flow (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net Operating Cash | $100 | $77 | $77 |
| Net Investing Cash | -$38 | $101 | -$47 |
| Net Financing Cash | -$60 | -$168 | -$58 |
| Net Change in Cash | $3 | $10 | -$28 |
| Cash at Beginning of Period | $66 | $55 | $85 |
| Cash at End of Period | $60 | $66 | $55 |
| Capital Expenditure | -$38 | -$38 | -$34 |
| Assets (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Assets | |||
| Cash and Cash Equivalents | $60 | $66 | $55 |
| Accounts Receivable | $78 | $80 | $78 |
| Inventories | $152 | $163 | $182 |
| Other Current Assets | $57 | $40 | $196 |
| Asset Summary | |||
| Total Current Assets | $348 | $350 | $510 |
| Tangible Fixed Assets | $338 | $424 | $386 |
| Intangible Assets | $106 | $168 | $179 |
| Total Assets | $1,308 | $1,511 | $1,627 |
| Liabilities (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Liabilities | |||
| Accounts Payable | $52 | $60 | $74 |
| Short-Term Debt | $ | $ | $3 |
| Other Current Liabilities | $102 | $98 | $155 |
| Liability Summary | |||
| Total Current Liabilities | $155 | $159 | $231 |
| Long-Term Debt | $219 | $265 | $415 |
| Other Long-Term Liabilities | $ | $ | $ |
| Total Liabilities | $551 | $664 | $843 |
| Stakeholder's Equity (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Equity | |||
| Common Stock | $53 | $52 | $52 |
| Retained Earnings | $413 | $486 | $451 |
| Equity Summary | |||
| Total Equity | $757 | $847 | $784 |
| Shares Outstanding | 589,982,702 | 587,824,987 | 583,759,437 |